Article

Predicting Breast Cancer Prognosis Using PR and PIK3CA Biomarkers: A Comparative Analysis of Diagnostic Groups

2024-12-02

Abstract excerpt

<title>Abstract</title> <p>Purpose To evaluate the prognostic significance of progesterone receptor (PR) expression and the PIK3CA mutation status in HR+/HER2 − breast cancer patients, with the goal of screening patients who may derive the greatest benefit from PI3K-targeted therapy. Methods A retrospective analysis was conducted on HR+/HER2 − breast cancer patients stratified by PR expression levels and PIK3CA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9511c0e9-0aa2-51b2-bf05-bb499591ec9d
DOI: 10.21203/rs.3.rs-5382358/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting Breast Cancer Prognosis Using PR and PIK3CA Biomarkers: A Comparative Analysis of Diagnostic GroupsDOI 10.21203/rs.3.rs-5382358/v1Read

A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer.Semantic proximity Read

The Predictive Role of PIK3CA Mutation Status on PI3K Inhibitors in HR+ Breast Cancer Therapy: A Systematic Review and Meta-Analysis.Semantic proximity Read

Survival analysis of patients with early breast cancer associated with PIK3CA mutationSemantic proximity Read

Analysis of PIK3CA Mutations with Clinicopathological Features and Prognosis in Breast cancer patients with Undergoing Neoadjuvant TherapySemantic proximity Read

PIK3CA mutations in breast cancerSemantic proximity Read

Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis.Semantic proximity Read

Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypesSemantic proximity Read

A combination of Nottingham prognostic index (NPI) and IHC4 score as a cost-effective tool in the risk stratification of breast cancer patientsSemantic proximity Read

Adherence to and optimization of guidelines for Risk of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter studySemantic proximity Read

Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway.Semantic proximity Read

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.Semantic proximity Read

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.Semantic proximity Read